Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial by Cudkowicz, Merit E, Prof, van den Berg, Leonard H, Prof, Shefner, Jeremy M, Prof, Mitsumoto, Hiroshi, Prof, Mora, Jesus S, MD, Ludolph, Albert, Prof, Hardiman, Orla, Prof, Bozik, Michael E, MD, Ingersoll, Evan W, PhD, Archibald, Donald, MPhil, Meyers, Adam L, MS, Dong, Yingwen, PhD, Farwell, Wildon R, MD, Kerr, Douglas A, MD

Get full text

Dexpramipexole effectively lowers blood and tissue eosinophils in subjects with chronic rhinosinusitis with nasal polyps by Prussin, Calman, MD, FAAAAI, Laidlaw, Tanya M., MD, FAAAAI, Panettieri, Reynold A., MD, Ferguson, Berrylin J., MD, Adappa, Nithin D., MD, Lane, Andrew P., MD, Lee, Stella, MD, Sullivan, Mary, Archibald, Don, MPhil, Dworetzky, Steven I., PhD, Hebrank, Greg, MD, Bozik, Michael E., MD

Get full text